Gonadal Function in Young to Middle Aged HIV-infected Men
1 other identifier
observational
315
1 country
1
Brief Summary
HIV infection is associated to premature decline of serum testosterone. However, prevalence and biochemical characterization of hypogonadism in HIV-infected men are still to be well defined. HIV-infection is strongly associated to erectile dysfunction in men, but preliminary data suggest that it is poorly associated with serum testosterone in this context.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedFirst Submitted
Initial submission to the registry
November 16, 2018
CompletedFirst Posted
Study publicly available on registry
November 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFebruary 9, 2021
February 1, 2021
4.6 years
November 16, 2018
February 8, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Serum total testosterone
From blood sample - unit of measurement ng/dL
Assessed only once at the moment of enrollment with liquid chromatography tandem mass spectrometry
Serum total testosterone
From blood sample - unit of measurement ng/dL
Assessed only once at the moment of enrollment with chemiluminiscent immunoassay
Secondary Outcomes (2)
Serum free testosterone
Calculated only once at the moment of enrollment
Score at IIEF questionnaire
Assessed only once at the moment of enrollment
Study Arms (1)
HIV-infected male patients
Male patients (age 18-50 years) with HIV-infection and ongoing HAART therapy No intervention is provided
Interventions
Eligibility Criteria
Cohort of Young-to-Middle Aged HIV-infected Patients
You may qualify if:
- Male gender
- Age 18-50 years
- HIV-infection
- Ongoing Highly Active Antiretroviral Therapy
You may not qualify if:
- Previous treatment with androgens, anti-androgens
- Severe liver insufficiency
- Severe renal insufficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliero - Universitaria di Modena
Modena, 41124, Italy
Biospecimen
Blood sample for hormonal assay
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 16, 2018
First Posted
November 20, 2018
Study Start
May 15, 2013
Primary Completion
December 31, 2017
Study Completion
December 31, 2018
Last Updated
February 9, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share